Progressive Fibrosing Interstitial Lung Disease in Pediatric Patients
📧 Sign up to get email alerts when something new happens for Progressive Fibrosing Interstitial Lung Disease in Pediatric Patients.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2024-12-13First treatment recommended for rare progressive lung conditions in children and adolescents
The EMA's CHMP issued a positive opinion to extend the indication of nintedanib (Ofev) to treat rare progressive lung conditions in children…